The purpose of HTA is to provide high-quality information to decision makers about the clinical e
Manufacturing biological medicines is generally more complex than the production of traditional (
There is no common European consensus on how to reward healthcare innovation.
Innovative medicines generally benefit from a certain period of intellectual property protection
The biotech industry proposes the development of shared European standards for HTAs to ensure the